EP2004156 - COMPOSITIONS FOR TRANSFECTION OF OLIGONUCLEOTIDES ACTIVE FOR GENE SILENCING AND THEIR BIOLOGICAL AND THERAPEUTICAL APPLICATIONS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 02.12.2011 Database last updated on 03.09.2024 | Most recent event Tooltip | 04.10.2013 | Lapse of the patent in a contracting state New state(s): HU | published on 06.11.2013 [2013/45] | Applicant(s) | For all designated states Polyplus-Transfection SA Boulevard Sébastien Brandt Bioparc BP 90018 67401 Illkirch Cedex / FR | [2008/52] | Inventor(s) | 01 /
NEUBERG, Patrick 25, rue Vincent Scotto 67400 Illkirch / FR | 02 /
BOLCATO BELLEMIN, Anne-Laure 39, Rue du Markstein 67100 Strasbourg / FR | 03 /
BEHR, Jean-Paul 7, rue Eugénie 67100 Strasbourg / FR | 04 /
ERBACHER, Patrick 6, Rue Pont Neuf 67230 Benfeld / FR | [2008/52] | Representative(s) | Peaucelle, Chantal, et al Cabinet Armengaud Aîné 3, Avenue Bugeaud 75116 Paris / FR | [N/P] |
Former [2008/52] | Peaucelle, Chantal, et al Cabinet Armengaud Aîné 3, Avenue Bugeaud 75116 Paris / FR | Application number, filing date | 07734913.2 | 05.04.2007 | [2008/52] | WO2007IB01774 | Priority number, date | EP20060290563 | 06.04.2006 Original published format: EP 06290563 | US20060789575P | 06.04.2006 Original published format: US 789575 P | [2008/52] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2008004058 | Date: | 10.01.2008 | Language: | EN | [2008/02] | Type: | A2 Application without search report | No.: | EP2004156 | Date: | 24.12.2008 | Language: | EN | The application published by WIPO in one of the EPO official languages on 10.01.2008 takes the place of the publication of the European patent application. | [2008/52] | Type: | B1 Patent specification | No.: | EP2004156 | Date: | 26.01.2011 | Language: | EN | [2011/04] | Search report(s) | International search report - published on: | EP | 12.02.2009 | Classification | IPC: | A61K31/7115, A61K31/41, A61K31/42, A61K31/425, A61P31/00, A61P35/00 | [2009/16] | CPC: |
A61K48/0025 (EP,US);
A61K48/00 (EP,KR,US);
A61K31/40 (KR);
A61K31/4164 (EP,US);
A61K31/4184 (EP,US);
A61K31/7088 (EP,US);
A61K48/0033 (EP,US);
A61K9/1271 (EP,US);
A61P31/00 (EP);
A61P31/12 (EP);
A61P33/00 (EP);
A61P35/00 (EP);
C12N15/88 (EP,US)
(-)
|
Former IPC [2008/52] | A61K31/00 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2008/52] | Extension states | AL | Not yet paid | BA | Not yet paid | HR | Not yet paid | MK | Not yet paid | RS | Not yet paid | Title | German: | ZUSAMMENSETZUNGEN ZUR TRANSFEKTION VON GEN-SILENCING-AKTIVEN OLIGONUKLEOTIDEN UND DEREN BIOLOGISCHE UND THERAPEUTISCHE ANWENDUNGEN | [2008/52] | English: | COMPOSITIONS FOR TRANSFECTION OF OLIGONUCLEOTIDES ACTIVE FOR GENE SILENCING AND THEIR BIOLOGICAL AND THERAPEUTICAL APPLICATIONS | [2008/52] | French: | COMPOSITIONS DE TRANSFECTION D'OLIGONUCLÉOTIDES ACTIFS DANS LE BLOCAGE DES GÈNES, ET APPLICATIONS BIOLOGIQUES ET THÉRAPEUTIQUES DE CELLES-CI | [2008/52] | Entry into regional phase | 16.10.2008 | National basic fee paid | 16.10.2008 | Designation fee(s) paid | 16.10.2008 | Examination fee paid | Examination procedure | 16.10.2008 | Examination requested [2008/52] | 29.05.2009 | Despatch of a communication from the examining division (Time limit: M06) | 08.12.2009 | Reply to a communication from the examining division | 12.03.2010 | Communication of intention to grant the patent | 09.07.2010 | Fee for grant paid | 09.07.2010 | Fee for publishing/printing paid | Opposition(s) | 27.10.2011 | No opposition filed within time limit [2012/01] | Fees paid | Renewal fee | 23.04.2009 | Renewal fee patent year 03 | 13.03.2010 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | CY | 26.01.2011 | CZ | 26.01.2011 | EE | 26.01.2011 | HU | 26.01.2011 | LT | 26.01.2011 | LV | 26.01.2011 | MT | 26.01.2011 | PL | 26.01.2011 | RO | 26.01.2011 | SI | 26.01.2011 | SK | 26.01.2011 | TR | 26.01.2011 | BG | 26.04.2011 | GR | 27.04.2011 | IS | 26.05.2011 | PT | 26.05.2011 | [2013/45] |
Former [2013/44] | CY | 26.01.2011 | |
CZ | 26.01.2011 | ||
EE | 26.01.2011 | ||
LT | 26.01.2011 | ||
LV | 26.01.2011 | ||
MT | 26.01.2011 | ||
PL | 26.01.2011 | ||
RO | 26.01.2011 | ||
SI | 26.01.2011 | ||
SK | 26.01.2011 | ||
TR | 26.01.2011 | ||
BG | 26.04.2011 | ||
GR | 27.04.2011 | ||
IS | 26.05.2011 | ||
PT | 26.05.2011 | ||
Former [2012/05] | CY | 26.01.2011 | |
CZ | 26.01.2011 | ||
EE | 26.01.2011 | ||
LT | 26.01.2011 | ||
LV | 26.01.2011 | ||
MT | 26.01.2011 | ||
PL | 26.01.2011 | ||
RO | 26.01.2011 | ||
SI | 26.01.2011 | ||
SK | 26.01.2011 | ||
BG | 26.04.2011 | ||
GR | 27.04.2011 | ||
IS | 26.05.2011 | ||
PT | 26.05.2011 | ||
Former [2011/49] | CY | 26.01.2011 | |
CZ | 26.01.2011 | ||
EE | 26.01.2011 | ||
LT | 26.01.2011 | ||
LV | 26.01.2011 | ||
PL | 26.01.2011 | ||
RO | 26.01.2011 | ||
SI | 26.01.2011 | ||
SK | 26.01.2011 | ||
BG | 26.04.2011 | ||
GR | 27.04.2011 | ||
IS | 26.05.2011 | ||
PT | 26.05.2011 | ||
Former [2011/37] | CY | 26.01.2011 | |
LT | 26.01.2011 | ||
LV | 26.01.2011 | ||
PL | 26.01.2011 | ||
SI | 26.01.2011 | ||
BG | 26.04.2011 | ||
GR | 27.04.2011 | ||
IS | 26.05.2011 | ||
PT | 26.05.2011 | ||
Former [2011/36] | LT | 26.01.2011 | |
LV | 26.01.2011 | ||
PL | 26.01.2011 | ||
GR | 27.04.2011 | ||
IS | 26.05.2011 | ||
PT | 26.05.2011 | Cited in | International search | [Y]WO9845317 (GENZYME CORP [US]) [Y] 1-30 * the whole document *; | [Y]WO9958152 (UNIV FLORIDA [US]) [Y] 1-30 * the whole document *; | [Y]US6071890 (SCHEULE RONALD K [US], et al) [Y] 1-30 * the whole document *; | [A]WO0172280 (BIOSPHERE MEDICAL INC [US], et al) [A] 1-28* the whole document *; | [Y]US2003044983 (HERWEIJER HANS [US], et al) [Y] 1-30 * the whole document *; | [YP] - LV ET AL, "Toxicity of cationic lipids and cationic polymers in gene delivery", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, (20060810), vol. 114, no. 1, ISSN 0168-3659, pages 100 - 109, XP005586193 [YP] 1-28 * the whole document * DOI: http://dx.doi.org/10.1016/j.jconrel.2006.04.014 | [Y] - HYVONEN Z ET AL, "Novel cationic amphiphilic 1,4-dihydropyridine derivatives for DNA delivery", BIOCHIMICA ET BIOPHYSICA ACTA. BIOMEMBRANES, AMSTERDAM, NL, (20001220), vol. 1509, no. 1-2, ISSN 0005-2736, pages 451 - 466, XP004273389 [Y] 1-28 * the whole document * DOI: http://dx.doi.org/10.1016/S0005-2736(00)00327-8 | [Y] - FISCHER A ET AL, "Synthesis of new amphiphilic cationic block copolymers and study of their behaviour in aqueous medium as regards hydrophobic microdomain formation", POLYMER, ELSEVIER SCIENCE PUBLISHERS B.V, GB, (20010201), vol. 42, no. 4, ISSN 0032-3861, pages 1441 - 1448, XP004219060 [Y] 1-28 * the whole document * DOI: http://dx.doi.org/10.1016/S0032-3861(00)00493-6 | [A] - PLANK C ET AL, "Branched cationic peptides for gene delivery : role of type and number of cationic residues in formation and in vitro activity of DNA polyplexes", HUMAN GENE THERAPY, MARY ANN LIEBERT, NEW YORK ,NY, US, (19990120), vol. 10, no. 2, ISSN 1043-0342, pages 319 - 332, XP002349695 [A] 1-28 * the whole document * DOI: http://dx.doi.org/10.1089/10430349950019101 |